Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  European Journal of Pharmacology

• Publication date

  1994-01-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(94)90439-1PMID 8137868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fine-structural localization of aldose reductase and ouabain-sensitive, K+-dependent p-nitro-phenylphosphatase in rat peripheral nerve

  2004cited by this paper
• Decreased endoneurial fluid electrolytes in normal rat sciatic nerve after aldose reductase inhibition.

  1993cited by this paper
• Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus

  1993cited by this paper
• Effect of Niceritrol on Streptozocin-Induced Diabetic Neuropathy in Rats

  1992cited by this paper
• A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group.

  1992cited by this paper
• Effects of Chronic α-Adrenergic Receptor Blockade on Peripheral Nerve Conduction, Hypoxic Resistance, Polyols, Na+-K+-ATPase Activity, and Vascular Supply in STZ-D Rats

  1991cited by this paper
• Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits.

  1991cited by this paper
• Prevention of Hemodynamic and Vascular Albumin Filtration Changes in Diabetic Rats by Aldose Reductase Inhibitors

  1989cited by this paper
• Chronic low frequency electrical activation for one week corrects nerve conduction velocity deficits in rats with diabetes of three months duration

  1989cited by this paper
• Effect of Prostaglandin E1 Analogue TFC 612 on Diabetic Neuropathy in Streptozocin-Induced Diabetic Rats Comparison With Aldose Reductase Inhibitor ONO 2235

  1989cited by this paper
• A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes.

  1989cited by this paper
• Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy.

  1989cited by this paper
• The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells

  1989cited by this paper
• Regional blood flow in resting and stimulated sciatic nerve of diabetic rats.

  1988cited by this paper
• A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.

  1988cited by this paper
• Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium

  1988cited by this paper
• Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic rats.

  1988cited by this paper
• The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrations

  1987cited by this paper
• Sorbinil Partially Prevents Decreased Erythrocyte Deformability in Experimental Diabetes Mellitus

  1987cited by this paper
• Tolrestat, an Aldose Reductase Inhibitor, Prevents Nerve Dysfunction in Conscious Diabetic Rats

  1987cited by this paper
• The medicinal chemistry of aldose reductase inhibitors.

  1987cited by this paper
• Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.

  1984cited by this paper
• Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

  1983cited by this paper
• Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

  1983cited by this paper
• Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibition

  1983cited by this paper
• The Effect of Aldose Reductase Inhibition on Motor Nerve Conduction Velocity in Diabetic Rats

  1982cited by this paper
• Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.

  1982cited by this paper
• Immunohistochemical Localization of Aldose Reductase: I. Enzyme Purification and Antibody Preparation—Localization in Peripheral Nerve, Artery, and Testis

  1980cited by this paper
• Reduced Erythrocyte Deformability in Diabetes

  1978cited by this paper

• An Update On Rodent Model Studies In Diabetic Neuropathy: A Brief Communication

  2016cites this paper
• Monitoring of Diabetic Late Complication

  2015cites this paper
• Guaifenesin derivatives promote neurite outgrowth and protect diabetic mice from neuropathy.

  2013cites this paper
• Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats

  2012cites this paper
• Aldose Reductase Deficiency Improves Wallerian Degeneration and Nerve Regeneration in Diabetic thy1-YFP Mice

  2010cites this paper
• Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.

  2008cites this paper
• Epidermal innervation and thermal nociception in rodent models of diabetic neuropathy

  2008influential citation
• Novel sites of aldose reductase immunolocalization in normal and streptozotocin‐diabetic rats

  2006cites this paper
• Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin.

  2005cites this paper
• A hypothalamic-testicular neural pathway is influenced by brain catecholamines, but not testicular blood flow.

  2004cites this paper
• Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor

  2004cites this paper
• Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy.

  2003cites this paper
• An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

  2002cites this paper
• Nerve and ganglion blood flow in diabetes: an appraisal.

  2002cites this paper
• Antidiabetic activity 1

  2002cites this paper
• Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats.

  2000cites this paper
• Protection of Sensory Function and Antihyperalgesic Properties of a Prosaposin-derived Peptide in Diabetic Rats

  2000cites this paper
• Altered non-adrenergic non-cholinergic neurotransmission in gastric fundus from streptozotocin-diabetic rats.

  2000cites this paper
• Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats.

  1999cites this paper
• Impact of diabetes on CNS: role of signal transduction cascade.

  1999cites this paper
• Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

  1999cites this paper
• Effects of hindlimb temperature on sciatic nerve laser Doppler vascular conductance in control and streptozotocin-diabetic rats.

  1999cites this paper
• Aldose reductase: a window to the treatment of diabetic complications?

  1998cites this paper
• Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes.

  1998cites this paper
• Effects of the peptide HP228 on nerve disorders in diabetic rats.

  1998cites this paper
• Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.

  1998cites this paper
• Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.

  1998cites this paper
• Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase

  1998cites this paper
• Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.

  1998cites this paper
• Effects of body and hindlimb temperature on laser Doppler blood flow and vascular conductance in rat sciatic nerve and skeletal muscle.

  1997cites this paper
• Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

  1997cites this paper
• Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats.

  1997cites this paper
• Aldose Reductase Inhibition Increases CNTF-Like Bioactivity and Protein in Sciatic Nerves From Galactose-Fed and Normal Rats

  1997cites this paper
• Effects of diabetes on reactivity of sciatic vasa nervorum in rats.

  1997cites this paper
• Cardiovascular autoregulation in insulin dependent diabetic patients

  1997cites this paper
• Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve.

  1996cites this paper
• Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects.

  1996cites this paper
• Effects of a nonpeptide endothelin-1 ETA antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system.

  1996cites this paper
• Effects of the sulphydryl donor N‐acetyl‐L‐cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats

  1996cites this paper
• Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats

  1996cites this paper
• Tactile allodynia and formalin hyperalgesia in streptozotocin‐diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine

  1996cites this paper
• Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats.

  1996cites this paper
• Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes.

  1996cites this paper
• Tolrestat improves nerve regeneration after crush injury in streptozocin-induced diabetic rats.

  1996cites this paper
• Comparison of the effects of ascorbyl gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats.

  1996cites this paper
• Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats

  1996cites this paper
• The aldose reductase inhibitor sorbinil does not prevent the impairment in nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic rats.

  1996cites this paper
• Metabolic Alterations of Peripheral Nerve in Diabetes

  1996cites this paper
• Neuroprotective effects of carvedilol in diabetic rats: prevention of defective peripheral nerve perfusion and conduction velocity

  1995cites this paper
• Nerve function in galactosaemic rats: effects of evening primrose oil and doxazosin.

  1995cites this paper
• Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.

  1995cites this paper
• Impaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway.

  1995cites this paper
• Pathology and pathogenetic mechanisms of diabetic neuropathy.

  1995cites this paper
• Different effects of two aldose reductase inhibitors on nociception and prostaglandin E.

  1995cites this paper
• The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.

  1994cites this paper